David Lowrance
Finanzdirektor/CFO bei SAVARA INC.
Vermögen: 366 480 $ am 30.04.2024
Aktive Positionen von David Lowrance
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
SAVARA INC. | Verwaltungsdirektor | 13.12.2022 | - |
Finanzdirektor/CFO | 27.04.2017 | - | |
Unternehmenssekretär | 01.07.2017 | 13.12.2022 | |
Washington Biotechnology & Biomedical Association | Direktor/Vorstandsmitglied | 01.07.2014 | - |
Karriereverlauf von David Lowrance
Ehemalige bekannte Positionen von David Lowrance
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Edgemont Pharmaceuticals LLC
Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Edgemont Pharmaceuticals LLC develops and provides products for psychiatric disorders. The company was founded by Douglas A. Saltel in 2008 and is headquartered in Austin, TX. | Finanzdirektor/CFO | 01.09.2014 | 01.10.2016 |
Treasurer | 01.09.2014 | 01.10.2016 | |
ACUCELA INC | Finanzdirektor/CFO | 01.04.2011 | 19.09.2014 |
Unternehmenssekretär | 01.04.2011 | 19.09.2014 | |
CUMBERLAND PHARMACEUTICALS INC. | Finanzdirektor/CFO | 01.03.2003 | 04.04.2011 |
Aravas, Inc.
Aravas, Inc. Pharmaceuticals: MajorHealth Technology Aravas, Inc. develops innovative drugs for the treatment of serious and life-threatening conditions. It develops dry powder formulations for various therapeutic molecules, including antibiotics, corticosteroids, nucleic acids, and insoluble and soluble molecules. The firm’s products include AeroVanc, an inhaled dry powder form of vancomycin in a capsule-based inhaler to treat methicillin-resistant staphylococcus aureus infections in patients with cystic fibrosis or other lung-compromising conditions; and AeroCort, a high performance inhaled corticosteroid product for the treatment of asthma in children. The company was founded by Cory Berkland, Chris Marich, Robert N. Neville, Taneli Jouhikainen, Chal Lenge and George Laurence in March 2007 and is headquartered in Austin, TX. | Finanzdirektor/CFO | 01.11.2016 | - |
KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Finanzdirektor/CFO | - | - |
BORGWARNER INC. | Finanzdirektor/CFO | - | - |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Corporate Officer/Principal | 01.01.1994 | - |
Ausbildung von David Lowrance
University of Georgia | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 9 |
Slowenien | 2 |
Japan | 2 |
Operativ
Director of Finance/CFO | 7 |
Corporate Secretary | 2 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 7 |
Consumer Services | 2 |
Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 4 |
---|---|
CUMBERLAND PHARMACEUTICALS INC. | Health Technology |
BORGWARNER INC. | Producer Manufacturing |
KUBOTA PHARMACEUTICAL HOLDINGS CO., LTD. | Health Technology |
SAVARA INC. | Health Technology |
Private Unternehmen | 5 |
---|---|
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Acucela, Inc.
Acucela, Inc. Pharmaceuticals: MajorHealth Technology Acucela, Inc. operates as a clinical-stage biotechnology company. It discovers and develops novel therapeutics to treat and show the progression of sight-threatening ophthalmic diseases. Its pipeline includes drug candidates and therapeutics for the treatment of age related macular degeneration, cataracts, presbyopia, diabetic retinopathy, retinitis igmentosa and Stargardt disease. The company was founded by Ryo Kubota in April 2002 and is headquartered in Seattle, WA. | Health Technology |
Washington Biotechnology & Biomedical Association | |
Edgemont Pharmaceuticals LLC
Edgemont Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Edgemont Pharmaceuticals LLC develops and provides products for psychiatric disorders. The company was founded by Douglas A. Saltel in 2008 and is headquartered in Austin, TX. | Health Technology |
Aravas, Inc.
Aravas, Inc. Pharmaceuticals: MajorHealth Technology Aravas, Inc. develops innovative drugs for the treatment of serious and life-threatening conditions. It develops dry powder formulations for various therapeutic molecules, including antibiotics, corticosteroids, nucleic acids, and insoluble and soluble molecules. The firm’s products include AeroVanc, an inhaled dry powder form of vancomycin in a capsule-based inhaler to treat methicillin-resistant staphylococcus aureus infections in patients with cystic fibrosis or other lung-compromising conditions; and AeroCort, a high performance inhaled corticosteroid product for the treatment of asthma in children. The company was founded by Cory Berkland, Chris Marich, Robert N. Neville, Taneli Jouhikainen, Chal Lenge and George Laurence in March 2007 and is headquartered in Austin, TX. | Health Technology |
- Börse
- Insiders
- David Lowrance
- Erfahrung